LGC supports British Pharmacopoeia 2022

Blog - LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances

04 November 2021

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK

17 May 2022